ANIL KUMAR: Open Payments
NPI 1548209547 · STONEHAM, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,311 in 45 payments from 13 companies in 2025. Trend: 2023 $1,123 · 2024 $1,190 · 2025 $1,311
Food & beverage: $1,311
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $368 |
| ABBVIE INC. | 13 | $336 |
| Lundbeck LLC | 5 | $151 |
| Abbott Laboratories | 2 | $116 |
| Axsome Therapeutics, Inc. | 2 | $66 |
| Globus Medical, Inc. | 2 | $59 |
| Nalu Medical, Inc. | 1 | $47 |
| Siemens Medical Solutions USA, Inc. | 1 | $39 |
| Avanos Medical | 1 | $30 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
Products named: RELISTOR, UBRELVY, VYEPTI, QULIPTA, PROCLAIM, Symbravo, Senza, Nalu Neurostimulation System.
Industry payments across MA — which companies pay providers there.
